Jack in the Box Inc. (JACK) Drops 15.33% on February 18

Equities Staff  |

Jack in the Box Inc. (JACK) was one of the Russell 2000's biggest losers for Thursday February 18 as the stock slid 15.33% to $65.12, a loss of $-11.79 per share. Starting at an opening price of $63.70 a share, the stock traded between $62.20 and $65.70 over the course of the trading day. Volume was 7.13 million shares over 49,491 trades, against an average daily volume of 714,453 shares and a total float of 35.79 million.

The losses send Jack in the Box Inc. down to a market cap of $2.33 billion. In the last year, Jack in the Box Inc. has traded between $99.99 and $63.94, and its 50-day SMA is currently $75.52 and 200-day SMA is $80.77.

The stock has a P/E Ratio of 27.

Jack In The Box Inc owns, operates and franchises quick-service restaurants and Qdoba Mexican Grill fast-casual restaurants.

Jack in the Box Inc. is based out of San Diego, CA and has some 20,700 employees. Its CEO is Leonard A. Comma.

For a complete fundamental analysis analysis of Jack in the Box Inc., check out Equities.com’s Stock Valuation Analysis report for JACK. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer



Symbol Last Price Change % Change










Q BioMed CEO provides a Corporate Update

Denis Corin, CEO of Q BioMed Inc. ”Q“, a biomedical acceleration and development company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides a corporate update.

Emerging Growth

Lexaria Bioscience Corp

Lexaria Bioscience Corp is a food sciences company. It has two distinct consumer product brands: ViPova and Lexaria Energy. It uses patent pending technology to infuse hemp oil ingredients within…